封面
市場調查報告書
商品編碼
1618197

醫療保健 3D 列印市場機會、成長動力、產業趨勢分析和 2024 年至 2032 年預測

Healthcare 3D Printing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球醫療保健3D 列印市場價值為29 億美元,預計2024 年至2032 年複合年成長率為18.6%。 。 3D列印技術在臨床環境中的廣泛使用是促進市場成長的主要因素。這種創新方法可以創建高度客製化的醫療設備,包括專門為滿足個別患者的解剖學需求而量身定做的植入物、義肢和手術器械。這種客製化可以顯著提高治療效果。

此外,3D 列印也被用來產生準確的解剖模型,以幫助制定手術計劃,減少出錯的可能性並提高手術過程中的精確度。該市場按產品類型細分,包括基於噴墨、基於注射器、基於雷射和磁懸浮技術。基於注射器的細分市場到 2023 年將產生約 12 億美元的收入。基於注射器的系統的精度和控制使其非常適合醫療保健環境,特別是在研究和再生醫學領域。

它們在管理水凝膠和生物墨水等各種材料方面的多功能性,進一步鞏固了它們在組織工程和藥物測試中的作用。在審查應用時,醫療保健 3D 列印市場涵蓋醫療、牙科和生物感測器領域。預計醫療應用領域在預測期內將產生最高收入,達到 68 億美元。此細分市場涵蓋骨科和心血管植入物等重要領域,使其成為醫療保健提供者和研究人員的焦點。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 29億美元
預測值 138 億美元
複合年成長率 18.6%

醫療 3D 列印技術的進步可以生產個人化醫療設備和植入物,滿足患者獨特的解剖學需求,顯著提高治療效果和整體患者護理。北美在醫療保健3D 列印市場中佔有相當大的佔有率,到2023 年將產生11 億美元的收入。方案的採用已成為人們關注的焦點。在政府大量資金的支持下,生物列印和 3D 列印醫療設備領域的持續創新由北美領先的醫療機構和大學帶頭。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 技術進步
      • 擴展臨床應用
      • 對客製化植入物的需求不斷成長
      • 增加製造商和機構的研發投入
    • 產業陷阱與挑戰
      • 缺乏熟練的專業人員
      • 3D列印的高價格
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 報銷場景
  • 2023 年按產品定價分析
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢
  • 差距分析
  • 價值鏈分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 基於注射器
  • 基於噴墨
  • 基於雷射
  • 磁浮

第 6 章:市場估計與預測:按技術分類,2021 - 2032 年

  • 主要趨勢
  • 熔融沈積建模 (FDM)
  • 選擇性雷射燒結(SLS)
  • 立體光刻
  • 其他技術

第 7 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 醫療的
    • 藥品
    • 義肢和植入物
    • 組織和器官生成
  • 牙科
  • 生物感測器

第 8 章:市場估計與預測:按材料分類,2021 - 2032 年

  • 主要趨勢
  • 聚合物
  • 金屬和合金
  • 生物材料
  • 其他材料

第 9 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章:公司簡介

  • 3D Biotek
  • 3D Systems
  • Aprecia Pharmaceuticals
  • Aspect Biosystems
  • Cyfuse Biomedical
  • Dassault Systemes
  • Envision TEC
  • Materialise
  • Metamorph 3D print services
  • Nano3D Biosciences
  • Oceanz
  • REGENHU
  • Renishaw
  • Stratasys
  • Xometry
簡介目錄
Product Code: 1997

The Global Healthcare 3D Printing Market was valued at USD 2.9 billion in 2023 and is projected to grow at a CAGR of 18.6% from 2024 to 2032. This growth is largely driven by increased research and development investments from manufacturers and institutions, along with a broadening array of clinical applications. The expanding use of 3D printing technology in clinical settings is a major factor contributing to market growth. This innovative approach allows the creation of highly customized medical devices, including implants, prosthetics, and surgical instruments tailored specifically to meet the anatomical needs of individual patients. Such customization significantly enhances treatment outcomes.

Additionally, 3D printing is being utilized to produce accurate anatomical models that aid in surgical planning, reducing the likelihood of errors and improving precision during procedures. The market is segmented by product types, including inkjet-based, syringe-based, laser-based, and magnetic levitation technologies. The syringe-based segment generated around USD 1.2 billion in revenue in 2023. These systems are particularly advantageous in bioprinting applications, where tissues and organs are crafted using bio-inks that contain living cells. The precision and control of syringe-based systems make them highly suitable for healthcare environments, especially in research and regenerative medicine.

Their versatility in managing various materials, such as hydrogels and bio-inks, further cements their role in tissue engineering and drug testing. When examining applications, the healthcare 3D printing market encompasses the medical, dental, and biosensor sectors. The medical applications segment is projected to yield the highest revenue of USD 6.8 billion during the forecast period. This segment covers essential areas such as orthopedics and cardiovascular implants, making it a focal point for healthcare providers and researchers.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$2.9 Billion
Forecast Value$13.8 Billion
CAGR18.6%

The advancements in medical 3D printing technology allow the production of personalized medical devices and implants that cater to the unique anatomical needs of patients, significantly enhancing treatment efficacy and overall patient care. North America holds a substantial share of the healthcare 3D printing market, generating USD 1.1 billion in revenue in 2023. This region is expected to experience a CAGR of 18% from 2024 to 2032. The embrace of advanced medical devices and personalized treatment options has been pivotal in propelling the growth of 3D printing within healthcare. The ongoing innovations in bioprinting and 3D-printed medical devices, backed by significant government funding, are being spearheaded by leading healthcare institutions and universities in North America.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancements
      • 3.2.1.2 Extended clinical applications
      • 3.2.1.3 Rising demand for custom implants
      • 3.2.1.4 Increasing R&D investments from manufacturers and institutions
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Lack of skilled professionals
      • 3.2.2.2 High price associated with 3D printing
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Pricing analysis, by product, 2023
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends
  • 3.11 Gap analysis
  • 3.12 Value-chain analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Syringe based
  • 5.3 Inkjet based
  • 5.4 Laser based
  • 5.5 Magnetic levitation

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Fused deposition modelling (FDM)
  • 6.3 Selective laser sintering (SLS)
  • 6.4 Stereolithography
  • 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Medical
    • 7.2.1 Pharmaceuticals
    • 7.2.2 Prosthetics and implants
    • 7.2.3 Tissue and organ generation
  • 7.3 Dental
  • 7.4 Biosensors

Chapter 8 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Polymers
  • 8.3 Metals and alloys
  • 8.4 Biological materials
  • 8.5 Other materials

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 3D Biotek
  • 10.2 3D Systems
  • 10.3 Aprecia Pharmaceuticals
  • 10.4 Aspect Biosystems
  • 10.5 Cyfuse Biomedical
  • 10.6 Dassault Systemes
  • 10.7 Envision TEC
  • 10.8 Materialise
  • 10.9 Metamorph 3D print services
  • 10.10 Nano3D Biosciences
  • 10.11 Oceanz
  • 10.12 REGENHU
  • 10.13 Renishaw
  • 10.14 Stratasys
  • 10.15 Xometry